Source comparison
Sermorelin vs Synthetic hGH: Pulsatility vs Sustained Elevation
Synthetic recombinant human growth hormone (rhGH, somatropin) is not a secretagogue. It is the hormone itself, delivered exogenously. Administration of rhGH raises serum GH levels immediately and sustains them for 8–12 hours depending on dose and route, produc
This comparison does not assign a generated winner or score.
- Synthetic recombinant human growth hormone (rhGH, somatropin) is not a secretagogue. It is the hormone itself, delivered exogenously. Administration of rhGH raises serum GH levels immediately and sustains them for 8–12 hours depending on dose and route, producing a pharmacokinetic profile completely unlike the endogenous pulsatile pattern. Natural GH secretion occurs in discrete pulses, primarily during slow-wave sleep and in response to fasting or exercise, with interpulse GH concentrations near-undetectable. Synthetic hGH obliterates that pattern, maintaining tonic elevation that suppresses endogenous pituitary GH output through negative feedback at the hypothalamic level. Continuous exogenous GH reduces GHRH secretion and upregulates somatostatin, shutting down the axis.
- Sermorelin does the opposite. Because it works through the GHRH receptor rather than delivering the hormone directly, it amplifies the body's existing GH pulses without replacing them. Pituitary cells retain their capacity to respond to endogenous GHRH even during sermorelin administration, and somatostatin retains its suppressive function during interpulse intervals. The result is enhanced pulsatile secretion. Higher-amplitude peaks, but preserved troughs. When sermorelin is discontinued, the pituitary axis returns to baseline function without the prolonged suppression seen after rhGH withdrawal. Research models studying GH dynamics, receptor sensitivity, or downstream IGF-1 signaling often require this preservation of physiological architecture.
- RhGH is the tool when the research question demands supraphysiological GH exposure. Growth plate studies, severe GH deficiency models, or investigations into IGF-1-independent GH effects. Sermorelin is the tool when you need to observe what happens when endogenous GH output is upregulated without dismantling the regulatory system that governs it. Different mechanisms, different applications.